[1] Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy[J].Intensive Care Med,2012,38(1):20-28. [2] Liu C, Mao Z, Kang H,et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials[J].Crit Care,2016,20(144):120-122. [3] Monchi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study[J].Intensive Care Med,2004,30(2):260-265. [4] Slowinski T, Morgera S, Joannidis M, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study[J].Crit Care,2015,19:349. [5] Nurmohamed S A, Vervloet M G, Girbes A R J, et al. Continuous Venovenous Hemofiltration with or without predilution regional citrate anticoagulation: A prospective study[J].Blood Purif,2007,25(4):316-323. [6] Schilder L, Nurmohamed S A, Bosch F H, et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial[J].Crit Care,2014,18(4):472. [7] 吴彼得,陈珊莹,沈长福,等. 血液净化治疗重症有机磷农药中毒的临床研究[J].医学临床研究,2008(6):963-965. [8] 郭正科,谭震武. 血液净化在老年急性肾功能衰竭中的应用研究[J].医学临床研究,2006(5):762-764. [9] Stucker F, Ponte B, Tataw J, et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial[J].Crit Care,2015,19(1):91. (本文编辑:王沪湘) [收稿日期] 2017-08-30
2017, Vol. 34 
